125 related articles for article (PubMed ID: 29631451)
1. Hypoechoic liver in fetuses with trisomy 21.
Omar PM; Lim WT; Ting YH; Lao TT; Law KM; Cheung AHK; Ng JKM; Leung TY
J Matern Fetal Neonatal Med; 2019 Oct; 32(19):3315-3317. PubMed ID: 29631451
[TBL] [Abstract][Full Text] [Related]
2. Four cases of fetal hypoechoic hepatomegaly associated with Trisomy 21 and transient abnormal myelopoiesis.
Kikuchi A; Tamura N; Ishii K; Takakuwa K; Matsunaga M; Sudo N; Tanaka K
Prenat Diagn; 2007 Jul; 27(7):665-9. PubMed ID: 17437323
[TBL] [Abstract][Full Text] [Related]
3. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
[TBL] [Abstract][Full Text] [Related]
4. Elevated delta OD 450 due to transient abnormal myelopoiesis in a Down syndrome fetus with hepatosplenomegaly on ultrasound.
Mancuso A; Rijhsinghani A
Prenat Diagn; 2014 Mar; 34(3):299-301. PubMed ID: 24353262
[TBL] [Abstract][Full Text] [Related]
5. Hypoechoic hepatomegaly associated with transient abnormal myelopoiesis provides clues to trisomy 21 in the third-trimester fetus.
Hamada H; Yamada N; Watanabe H; Okuno S; Fujiki Y; Kubo T
Ultrasound Obstet Gynecol; 2001 May; 17(5):442-4. PubMed ID: 11380972
[TBL] [Abstract][Full Text] [Related]
6. Detection Rate and Sonographic Signs of Trisomy 21 Fetuses at 14-17 Weeks of Gestation.
Bronshtein E; Solt I; Bronshtein M; Gover A; Wolman I; Blumenfeld Z
Isr Med Assoc J; 2017 Jan; 19(1):8-12. PubMed ID: 28457106
[TBL] [Abstract][Full Text] [Related]
7. Prenatal therapy in transient abnormal myelopoiesis: a systematic review.
Tamblyn JA; Norton A; Spurgeon L; Donovan V; Bedford Russell A; Bonnici J; Perkins K; Vyas P; Roberts I; Kilby MD
Arch Dis Child Fetal Neonatal Ed; 2016 Jan; 101(1):F67-71. PubMed ID: 25956670
[TBL] [Abstract][Full Text] [Related]
8. [Fetal hepatosplenomegaly in the third trimester: A sign of leukemia in fetuses with Down syndrome].
Fouché C; Ramos A; Esperandieu O; Briault S; Martin JG; Desroches A
J Gynecol Obstet Biol Reprod (Paris); 2010 Dec; 39(8):667-71. PubMed ID: 20692111
[TBL] [Abstract][Full Text] [Related]
9. Prenatal sonographic findings and hematological abnormalities in fetuses with transient abnormal myelopoiesis with Down syndrome.
Hojo S; Tsukimori K; Kitade S; Nakanami N; Hikino S; Hara T; Wake N
Prenat Diagn; 2007 Jun; 27(6):507-11. PubMed ID: 17345586
[TBL] [Abstract][Full Text] [Related]
10. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
11. Antenatal diagnosis of transient abnormal myelopoiesis associated with Down syndrome.
Siva S; Smoleniec J
Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):119-20. PubMed ID: 10099767
[No Abstract] [Full Text] [Related]
12. Correlation of prenatal sonographic diagnosis and morphologic findings of fetal autopsy in fetuses with trisomy 21.
Szigeti Z; Csaba A; Pete B; Hajdú J; Papp Z; Papp C
J Ultrasound Med; 2007 Jan; 26(1):61-8; quiz 69-70. PubMed ID: 17182710
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis of 46,XX,DER(13;21)(Q10;Q10),+21 and transient abnormal myelopoiesis in a fetus with hepatosplenomegaly and spontaneous resolution of fetal ascites.
Chen CP; Tsai FJ; Chern SR; Chang TY; Hsu CY; Lin HH; Wang W
Taiwan J Obstet Gynecol; 2009 Mar; 48(1):84-7. PubMed ID: 19346201
[No Abstract] [Full Text] [Related]
14. The performance of second trimester long bone ratios for Down syndrome screening is influenced by gestational age.
Wang E; Chen C; Glimco E; Grobman W
J Matern Fetal Neonatal Med; 2010 Jul; 23(7):642-5. PubMed ID: 20540658
[TBL] [Abstract][Full Text] [Related]
15. The association between prenatal atrioventricular septal defects and chromosomal abnormalities.
Morlando M; Bhide A; Familiari A; Khalil A; Morales-Roselló J; Papageorghiou AT; Carvalho JS
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():31-35. PubMed ID: 27888703
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of ultrasound markers in screening fetal trisomy 21].
Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
[TBL] [Abstract][Full Text] [Related]
17. Is the degree of fetal hepatosplenomegaly with transient abnormal myelopoiesis closely related to the postnatal severity of hematological abnormalities in Down syndrome?
Ogawa M; Hosoya N; Sato A; Tanaka T
Ultrasound Obstet Gynecol; 2004 Jul; 24(1):83-5. PubMed ID: 15229921
[TBL] [Abstract][Full Text] [Related]
18. [Prenatal diagnosis of trisomy 21: the Tunisian experience].
Chelli D; Dimassi K; Chaabouni M; Ben Saad M; Mssaed H; Bchir F; Zouaoui B; Sfar E; Gaigi S; Chelli H; Chanoufi B
Sante; 2008; 18(4):199-203. PubMed ID: 19810614
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing.
Lindquist A; Poulton A; Halliday J; Hui L
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):487-492. PubMed ID: 29226487
[TBL] [Abstract][Full Text] [Related]
20. Aberrant right subclavian artery as a new cardiac sign in second- and third-trimester fetuses with Down syndrome.
Chaoui R; Heling KS; Sarioglu N; Schwabe M; Dankof A; Bollmann R
Am J Obstet Gynecol; 2005 Jan; 192(1):257-63. PubMed ID: 15672034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
